Ozone Therapy for Chronic Fatigue Syndrome (ME/CFS): Promising Results from Recent Clinical Studies and Trials

Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME/CFS), is a complex, debilitating condition affecting up to 2.4% of the population in some estimates. Millions worldwide experience profound fatigue that rest cannot relieve, post-exertional malaise, cognitive issues, pain, and immune dysfunction. Conventional treatments focus mainly on symptom management, but many patients seek holistic options.  

Recent clinical studies on ozone therapy, specifically major oxygen-ozone autohemotherapy (O₂-O₃-AHT or MAH) show encouraging results for reducing ME/CFS fatigue. Italian researchers, led by Dr. Umberto Tirelli, have published key observational trials demonstrating significant symptom improvement with minimal side effects.  

This article reviews the latest evidence on ozone therapy for chronic fatigue syndrome, including the most recent 200-patient study (full PDF linked below), earlier trials, and how this therapy may work. Whether you’re exploring integrative options or researching ME/CFS treatments, here’s what the data shows.  

Understanding Chronic Fatigue Syndrome (ME/CFS)

ME/CFS is not “just being tired.” It is a serious physical illness lasting at least six months that severely impairs daily activities at home and work. Key features include:  
- Debilitating fatigue unrelieved by rest or sleep  
- Post-exertional malaise (symptoms worsen after physical or mental activity, often the next day)  
- Cognitive problems (“brain fog”)  
- Unrefreshing sleep  
- Widespread pain, immune, neurological, and autonomic symptoms  

Causes are not fully understood but often follow viral infections, with contributing factors like environmental toxins, trauma, genetics, and stress. Diagnosis relies on symptom-based criteria (e.g., IOM or Canadian Consensus Criteria) since no single biological marker exists.  

Prevalence: Estimates range from 0.4% to 2.4%, potentially affecting up to 120,000 people in New Zealand and 598,000 in Australia over a lifetime. Women are affected at roughly a 4:1 ratio compared to men, similar to other immuno-inflammatory conditions like lupus or multiple sclerosis.  

Limitations of Conventional ME/CFS Treatments
Standard medical approaches use pharmaceuticals such as antidepressants, pain relievers, or blood-pressure medications to manage individual symptoms. There is no universally accepted cure, and many patients report limited relief or unwanted side effects. This has driven interest in holistic therapies that address underlying issues like chronic inflammation, oxidative stress, and immune dysregulation.  

What Is Ozone Therapy?

Ozone therapy involves controlled medical-grade ozone (O₃) mixed with oxygen (O₂). In major autohemotherapy (the method used in ME/CFS studies), a small volume of the patient’s blood (typically 100–250 mL) is drawn, mixed with a precise ozone-oxygen blend, and reinfused. Protocols often follow guidelines from the Italian Society of Oxygen-Ozone Therapy (SIOOT).  

Ozone therapy is used worldwide for its documented effects on oxygenation, immune modulation, anti-inflammatory action, and redox balance. It is considered safe when performed correctly, with a strong track record in integrative clinics.  

How Ozone Therapy May Help Chronic Fatigue Syndrome

Researchers propose that oxygen-ozone autohemotherapy helps ME/CFS by:  
- Reducing systemic inflammation and oxidative stress  
- Modulating immune responses (e.g., balancing Treg/Th17 cells and activating Nrf2 pathways)  
- Improving cellular oxygenation and energy production  
- Addressing widespread low-grade infections or mitochondrial dysfunction often linked to ME/CFS  

These mechanisms make ozone therapy a promising adjunct for fatigue-dominant conditions.  

Latest Clinical Evidence: Ozone Therapy Trials for ME/CFS

The strongest published data comes from the same Italian research group (Tirelli et al.). All studies used major oxygen-ozone autohemotherapy and reported rapid fatigue relief with no adverse effects.  

1. Largest Study to Date (2021/2022) – 200 Patients

Title: Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy.  
Authors: Umberto Tirelli et al.  
Publication: Journal of Clinical Medicine, 2022 (online 2021).  

In this prospective observational study, 200 consecutive outpatients (mean age 33 years, 65.5% female) with confirmed ME/CFS received at least two weekly sessions of O₂-O₃-AHT (median 155 mL blood treated at 45 μg/mL ozone). Fatigue was measured using the Fatigue Severity Scale (FSS, 1–7 scale) before treatment and 30 days after the second session, with 3-month follow-up.  

Key results:  
- Mean FSS score dropped from 6.825 to 2.085 (≈69% improvement, p < 0.0001).  
- 43.5% of patients improved from the worst score (7) to the best (1).  
- 77.5% experienced clinically significant improvement (4–6 point drop).  
- Benefits were rapid, independent of age or sex, and sustained at 3-month follow-up.  
- No side effects reported.  

Full study PDF (open access): [Download here]  
**DOI**: 10.3390/jcm11010029  

This remains the largest dedicated trial of ozone therapy for ME/CFS.  

2. 2019 Study – 100 Patients
Tirelli et al. treated 100 CFS patients with oxygen-ozone therapy.  
**Results**: 70% showed >50% improvement in overall symptoms. No side effects. At the time, this was the largest reported series.  

3. 2018 Study – 65 Patients
An earlier observational study by Tirelli and colleagues in 65 CFS patients found ozone therapy to be effective. The authors concluded it was a promising option and called for larger trials with longer follow-up.  

A 2021 companion analysis from the same group also examined sex differences and confirmed consistent benefits across male and female patients.  

No large randomized controlled trials (RCTs) specifically for primary ME/CFS have been published since, though related research continues on overlapping conditions like fibromyalgia and post-viral fatigue. These observational studies provide the current clinical foundation for ozone therapy in ME/CFS.  

Is Ozone Therapy Right for You?

While results are promising, these are open-label observational studies without placebo controls. Larger, blinded RCTs would strengthen the evidence. Ozone therapy is not a cure but may offer meaningful fatigue relief as part of a holistic plan. Always consult a qualified medical practitioner experienced in ozone therapy before starting treatment.  

At Natural Ozone NZ, we offer high-quality ozone generators and accessories for professional or home use (including safe rectal insufflation protocols used in some integrative settings). Many of our customers report improved energy and wellbeing when combining ozone with lifestyle support.  

Ready to explore ozone therapy for chronic fatigue syndrome?
Download our FREE home ozone therapy guide for all the information you need to know in order to get started on your journey to better wellness.  

Last updated: May 2026. This article is for informational purposes only and is not medical advice.